Speaker
Professor, University of Alberta
Harley Kurata, University of Alberta, spoke at Ion Channel-Targeted Drug Development Summit (Boston, United States of America, 23–24 Sept 2026) in the session “Lipid-dependence of Kv7 Activator Drugs: Insights for Selective & Effective Potassium Channel Therapeutics”.
23–24 Sept 2026Boston, United States of America
Professor - Molecular Physiology & Biophysics, The University of Iowa
Vice President of R&D and Operations, Navega Therapeutics
Professor of Neurobiology, Harvard Medical School
Senior Principal Scientist, Novartis
Chief Scientific Officer, QurAlis Corp.
Chief Scientific Officer, Nocion Therapeutics, Inc.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Harley Kurata, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].